What strengths does Aldactone (spironolactone) come in?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Aldactone Available Strengths

Aldactone (spironolactone) is available in three tablet strengths: 25 mg, 50 mg, and 100 mg 1.

Specific Tablet Descriptions

The FDA-approved formulations are:

  • 25 mg tablets: Round, light yellow, film-coated tablets with "SEARLE and 1001" debossed on one side and "ALDACTONE and 25" on the other side 1

  • 50 mg tablets: Oval, light orange, scored, film-coated tablets with "SEARLE and 1041" debossed on the scored side and "ALDACTONE and 50" on the other side 1

  • 100 mg tablets: Round, peach-colored, scored, film-coated tablets with "SEARLE and 1031" debossed on the scored side and "ALDACTONE and 100" on the other side 1

Clinical Dosing Context

The availability of these three strengths allows for flexible dosing across different indications:

  • Heart failure: Typically initiated at 25 mg once daily, with potential titration to 50 mg once daily 1

  • Hypertension: Initial dosing ranges from 25-100 mg daily in single or divided doses 2, 3

  • Primary aldosteronism: Doses range from 100-400 mg daily 4, 5, 1

The scored 50 mg and 100 mg tablets can be split to achieve lower doses (such as 12.5 mg or 25 mg) when needed for patients with renal impairment or those at higher risk for hyperkalemia 6, 5.

Related Questions

What is the appropriate starting inpatient dose of spironolactone for an adult with mild‑to‑moderate heart failure with reduced ejection fraction, resistant hypertension, or primary hyperaldosteronism, and what monitoring and titration steps are recommended?
Is spironolactone (aldosterone antagonist) recommended as a first-line treatment for hypertension (HTN)?
What are the indications, dosing regimen, monitoring parameters, contraindications, and common adverse effects of spironolactone in adults?
Should a 78-year-old man with hypertension, diabetes mellitus, heart failure, normal renal function, currently taking metoprolol succinate and no diuretic, who has persistent hypertension and peripheral edema, be started on daily spironolactone?
What is the appropriate dosing, indications, and monitoring for spironolactone in a 12‑year‑old child?
What is the appropriate initial evaluation and management for a 21‑year‑old man presenting with hematospermia and hematuria?
What is the current name for polycystic ovary syndrome (PCOS)?
Should ceftriaxone be started in a child with cough and fever who has not responded to co-amoxiclav (amoxicillin/clavulanic acid)?
In a patient who has not responded adequately to rifaximin alone, should neomycin be added to the treatment regimen?
Is acute contrast-induced sialadenitis associated with HIV infection?
How should rifaximin (Xifaxan) 550 mg three times daily be used together with neomycin to treat hydrogen‑predominant small intestinal bacterial overgrowth (SIBO)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.